By www.reliableresearchtimes.com
Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Size, Status And Forecast 2024-2031 Story
125
$ 3900
Ventilator Associated Pneumonia (VAP) Therapeutics Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Achaogen Adenium Biotech Aridis Pharmaceuticals AstraZeneca Bayer Cardeas Pharma Destiny Pharma Dong-A Socio Holdings Lakewood-Amedex MedImmune Meiji Seika Pharma Merck & Co Motif Bio Nabriva Therapeutics Polyphor Shionogi & Co Tetraphase Pharmaceuticals The Medicines Company Theravance Biopharma Wockhardt Zavante Therapeutics